PPARGC1A and steatosis: The prominent hepatic increase in Ppargc1a mRNA in the HFD-fed group might be due to a compensatory response to enhance mitochondrial biogenesis and function in a steatosis environment, foster fatty acid oxidation, and reduce TG accumulation and secretion (Morris et al., 2012).